Clinical Trial Update: Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of Dimebon and Donepezil for Alzheimer's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Dimebon (latrepirdine)
• Donepezil (donepezil)

Snippet

Sponsor: Medivation, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED